Purdue ‘Light Up’ Cancer Technology Nears Commercialization


Purdue ‘Light Up’ Cancer Technology Nears Commercialization

The success of a resection is critical; currently, 30 to 55% of patients who undergo surgical resection develop a recurrence and do not survive. If a patient’s resection is complete, meaning all of the cancer was removed, the five-year survival rate climbs to 58%, compared to 33% for patients with an incomplete resection. However, Barys says “complete resection is becoming more and more difficult” with traditional methods.  


Source link